Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Al Mayadeen's correspondent in Caracas: The United States attacks another alleged drug-trafficking ship off the coast of Colombia in the Pacific Ocean
Palestinian official urges world to force 'Israel' to comply with ICJ ruling: AFP
Israeli media says Knesset approved bill to annex in West Bank in preliminary reading
Kremlin: As part of strategic nuclear force exercise, Cruiser Bryansk launched Sineva ballistic missile from Barents Sea.
Kremlin: Yars Intercontinental Ballistic Missile launched from Plesetsk Cosmodrome at Kura test site in Kamchatka.
Kremlin: Strategic nuclear forces exercise took place under Putin's leadership.
Lebanese MP Imad Al-Hout, following his meeting with the Grand Mufti of the Republic: Lebanon is the last country to move toward peace and normalization [with "Israel"]
Al Mayadeen's correspondent in South Lebanon: One martyr reported in Israeli drone strike targeting motorcycle in Ain Qana.
Israeli media: Sirens sound in Nahal Oz settlement in Gaza Envelope.
Syria: Local sources report that General Security forces targeted the camp of French fighters from the 'al-Ghuraba division' in the Idlib countryside with mortar and tank shells.

J&J ends trials for HIV vaccine

  • By Al Mayadeen English
  • Source: News websites
  • 19 Jan 2023 15:58
2 Min Read

The pharmaceutical giant gives up on its HIV vaccine after the shot failed a phase 3 trial.

  • x
  • In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe. (Getty images)
    In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe. (Getty images)

J&J is discontinuing its HIV vaccine after it failed a phase 3 trial, the latest setback in a decades-long quest to prevent one of the world's most heinous diseases.

The world’s largest pharma by revenue said on Wednesday that the trial’s data safety monitoring board found that the shot did not perform any better than placebos. As a result, the Mosaico study will end.

In a statement, Penny Heaton, M.D., Janessen's global vaccine lead, said that the company was disappointed, adding that "we remain steadfast in our commitment to advancing innovation in HIV, and we hope the data from Mosaico will provide insights for future efforts to develop a safe and effective vaccine."

Read next: Scientists might have cured a woman from HIV for the first time

Related News

Trump's aid freeze threatens millions as HIV/AIDS programs collapse

New HIV prevention drug may hit the market at $40 a year per patient

This is considered a major setback for the company and the millions of advocates, activists and global health officials who have worked to tackle HIV once and for all.

J&J discovered that the vaccine was about 25% effective, but the lower end of the confidence interval was less than 0. The Mosaico experiment used a one-year regimen that included four doses of the company's adenovirus vector vaccine, as well as a soluble protein in the third and fourth visits.

The National Institutes of Health and the United States Army Medical Research and Development Command collaborated on this research.

Aside from the public health implications, J&J's failure is the latest in a string of poor vaccine performances. First, the company's one-shot COVID vaccine has nearly vanished from global use; it is one of three shots approved in the United States. Moderna has also surpassed the company in the race to develop an RSV vaccine.

Read next: Moderna, IAVI launch trial for HIV vaccine using mRNA technology

  • AIDS
  • HIV
  • Johnson & Johnson
  • Moderna
  • J&J

Most Read

Yemeni Armed Forces Chief of Staff Major General Mohammad Abd al-Karim al-Ghamari , during a ceremony in an undisclosed locations in Yemen, undate (Yemeni Military Media)

Yemeni Armed Forces mourn martyred Chief of Staff al-Ghamari

  • Politics
  • 16 Oct 2025
From previous scenes of the Qassam Brigades targeting an Israeli D9 bulldozer with a Yassin 105 shell, east of Deir al-Balah. (Military Media of the Qassam Brigades)

US knew fatal Rafah blast cause was not Hamas op., says journalist

  • Politics
  • 20 Oct 2025
Smoke and fire rises after 'Israel' launched airstrikes on the village of Ansar, Lebanon, October 16, 2025 (social media)

'Israel' launches two waves of brutal strikes on east, south Lebanon

  • Politics
  • 16 Oct 2025
A woman with her purchased groceries walks out from an underground market, in Beijing, Wednesday, August 6, 2025. (AP Photo/Andy Wong)

Global brands in China face pressure from rising local rivals

  • Economy
  • 17 Oct 2025

Coverage

All
War on Gaza

Read Next

All
Nearly half of attacks in occupied al-Quds target Armenian Christians
Politics

Nearly half of attacks in occupied al-Quds target Armenian Christians

Greece rocked by EU farm subsidy scandal as dozens arrested
Economy

Greece rocked by EU farm subsidy scandal as dozens arrested

Netherlands holds talks with China after Beijing curbs Nexperia export.
Technology

Netherlands holds talks with China after Nexperia export's curb

Trump said to demand DOJ pay him $230 million for past cases: NYT
Politics

Trump said to demand DOJ pay him $230 mln for past cases: NYT

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS